Sign In
Buy PRPO
$21.65
+0.460 (+2.17%)
At Close: Jul 31, 2026
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?
03:42am, Saturday, 01'st Aug 2026
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $25.12 and traded as low as $20.20. Precipio
Precipio Announces Q2-2026 Shareholder Update Call
04:00pm, Friday, 31'st Jul 2026
NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
11:26am, Thursday, 16'th Jul 2026
Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote
Precipio to Present at the Planet MicroCap Las Vegas
05:00pm, Thursday, 11'th Jun 2026
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
11:31am, Friday, 22'nd May 2026
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
06:50pm, Monday, 18'th May 2026
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio Announces Q1 2026 Financial Results
05:00pm, Thursday, 14'th May 2026
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth Stable revenue performance driven by timing dynamics; expanding product pipeline e
Management team’s 2025 market-based Options have vested
05:00pm, Wednesday, 13'th May 2026
NEW HAVEN, Conn. , May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio
Management team's 2025 market-based Options have vested
05:00pm, Wednesday, 13'th May 2026
NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Prec
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
07:15am, Wednesday, 13'th May 2026
AI demand and pipeline growth headline top Zacks stock reports on NVIDIA, Mastercard and AbbVie.
Precipio Announces Q1-2026 Shareholder Update Call
05:00pm, Wednesday, 06'th May 2026
NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2026 shareholder update call on May 18th, 2026, at 5:0
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript
07:02pm, Thursday, 02'nd Apr 2026
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript
Head to Head Analysis: Precipio (NASDAQ:PRPO) & Healthcare Triangle (NASDAQ:HCTI)
01:23am, Thursday, 02'nd Apr 2026
Precipio (NASDAQ: PRPO - Get Free Report) and Healthcare Triangle (NASDAQ: HCTI - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two compa
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
05:00pm, Thursday, 12'th Mar 2026
NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2025 corporate update call on April 2nd, 2
